JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation is allowed to use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website for educational purpose only. Bodily introduction of any kind into humans and animals is strictly forbidden by law. This product should only be handled by licenced qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused as a drug, food and cosmetic.
FREE Shipping for orders over $200
For this product you will need: BACTERIOSTATIC WATER For reconstitution.
Growth hormone–releasing peptide 6 (GHRP-6) is a synthetic hexapeptide belonging to the growth hormone secretagogue research class. In experimental systems, it has been examined for its interaction with growth hormone secretagogue–associated receptor pathways and related signaling mechanisms. Within controlled laboratory environments, GHRP-6 is also often studied as a ghrelin-receptor–active peptide, in order to better understand such peptide-mediated endocrine signaling frameworks.
GHRP-6 is one of the earliest compounds in the peptide category, which first appeared in the 1980s. Under experimental conditions scientific investigations focused on its molecular structure, receptor affinity and metabolic and tissue-associated signaling pathways. GHRP-6 is intended strictly for laboratory and educational research use only. On our website, GHRP-6 for sale is limited to qualified research applications and is not approved for human use.
From Pubchem
IUPAC Name: ((2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamideSynonym: GH-Releasing peptide, 87616-84-0Molecular Formula: C46H56N12O6Molecular Weight: 873.0 g/molSequence: HWAWFKCAS Number: 87616-84-0PubChem CID: 9919153
GHRP-6 has been examined in experimental contexts concerned with peptide-mediated modulation of cardiovascular signaling microdomains. Investigative focus has centered on its interaction with redox-sensitive intracellular pathways, mitochondrial signaling equilibrium, and endocrine–cardiac communication interfaces.
Mechanistic studies have explored how growth hormone secretagogue–associated ligands intersect with stress-responsive transcriptional regulators, apoptotic signaling nodes, and peptide-driven attenuation of neurohormonal activation cascades. These observations have positioned GHRP-6 as a molecular probe for interrogating cardiac signal transduction under controlled research conditions [1,2].
Neurobiological investigations have evaluated GHRP-6 within frameworks addressing memory-associated synaptic signaling networks. Research interest has focused on presynaptic neurotransmitter dynamics and postsynaptic receptor plasticity associated with ghrelin receptor–mediated signaling.
Additional attention has been given to glutamatergic transmission systems, NMDA receptor subunit regulation, and downstream signaling events related to synaptic adaptability. These molecular interactions contribute to ongoing studies examining peptide-mediated modulation of hypothalamic arousal pathways [3,4].
Growth hormone secretagogue–related peptides have been investigated for their involvement in gastrointestinal regulatory mechanisms, particularly motility-associated signaling pathways. Laboratory analyses have examined GHRP-6 interactions with receptor-mediated enteric signaling systems, including cholinergic neurotransmission and peripheral neuroendocrine modulation.
Such studies support broader efforts to characterize peptide-driven gastrointestinal signaling under experimentally defined conditions [5,6].
Research efforts have explored GHRP-6 within experimental paradigms addressing cellular responses to ischemia-related metabolic stress. Investigations have evaluated associations with growth factor–responsive pathways, neuronal survival signaling markers, and post-insult synaptic reorganization processes.
These findings support continued use of GHRP-6 as a biochemical research tool for examining neural signaling resilience and adaptive molecular responses [7].
Studies examining GHRP-6 have addressed its relevance within tissue remodeling and extracellular matrix–associated signaling frameworks. Experimental analyses have focused on interactions with angiogenesis-related receptors, inflammatory mediator modulation, and cellular migration pathways.
Particular emphasis has been placed on CD36-linked signaling systems involved in vascular remodeling and tissue turnover, positioning GHRP-6 as a research compound for studying peptide-regulated structural signaling networks [8].
GHRP-6 is a synthetic hexapeptide and the earliest characterized member of the growth hormone–releasing peptide class. It remains a subject of laboratory investigation across endocrine signaling integration, neurobiological pathway modulation, and tissue remodeling research domains.
GHRP-6 is not approved by the FDA for clinical or therapeutic use and is intended exclusively for research and educational applications. Element CRP supplies GHRP-6 solely for qualified laboratory-based research purposes.
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue closely related to GHRP-2, featuring sequence variations that influence selectivity and pharmacological profile at the ghrelin receptor. The peptide demonstrates reliable stability for in vitro receptor pharmacology research applications.
Cell-based pharmacology research with GHRP-6 investigates GHSR-1a agonist activity through Gaq/calcium and Gas/cAMP coupling in transfected cell line backgrounds. Side-by-side comparisons against GHRP-2 and Ipamorelin map the broader selectivity landscape of the synthetic GHS class.
Element CRP supplies this product at 5mg per vial. USA-manufactured via solid-phase peptide synthesis and verified at 99%+ purity by HPLC and Mass Spectrometry. Reconstitution with bacteriostatic water required. Store lyophilised at -20°C; stable for 24 months.
WARNING: For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Element CRP is a chemical supplier. Element CRP is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Element CRP is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
